AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Biolife Solutions' Chief Human Resources Officer Aebersold Sarah sells 714 shares at $25.61/share.
ByAinvest
Wednesday, Sep 17, 2025 5:48 pm ET1min read
Biolife Solutions Inc. (BLFS) has announced that Chief Human Resources Officer Sarah Aebersold has sold 714 shares at a price of $25.61 per share on September 15, 2025.
Biolife Solutions Inc. (BLFS) has experienced significant executive share sales recently, with key officers selling a notable portion of their holdings. On September 11, 2025, Chief Scientific Officer Mathew Aby sold 630 shares, Chief Quality and Operations Officer Karen Foster sold 511 shares, and Chief Financial Officer Troy Wichterman sold 1,032 shares, all under a pre-established Rule 10b5-1(c) trading plan [1].The transactions saw Mathew Aby selling 630 shares at $26.83 per share, totaling $16,902. Foster sold 511 shares at the same price, totaling $13,710. Wichterman sold 1,032 shares at $26.83 per share, totaling $27,688. These sales reduced their respective shareholdings but did not significantly impact their overall ownership percentages [1].
On September 15, 2025, Chief Human Resources Officer Sarah Aebersold sold 714 shares at a price of $25.61 per share, totaling $18,215. This sale was also conducted under a pre-established Rule 10b5-1(c) trading plan [1].
These transactions provide insights into the executives' long-term commitment to the company and their confidence in Biolife Solutions' future prospects. However, they also highlight the potential for significant changes in the executive team's ownership structure.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet